If you need more lookups,
subscriptions start at $34 USD/month.
Anders Dahlstrand Location
Stockholm, SE
Anders Dahlstrand Work
Chief Business Officer and Co-Founder at Offspring Biosciences AB @ (January 2025 - Present)
Assoc. Professor @ (January 2002 - Present)
Principal Scientist @ AstraZeneca R&D (February 2002 - June 2012)
Senior Scientist @ AstraZeneca R&D (May 1998 - February 2002)
Research group leader @ (January 1994 - May 1998)
Post-doctoral fellow @ (February 1991 - December 1993)
Anders Dahlstrand Education
Karolinska Institutet
Dr. Med. Sci. (Molecular Neurobiology)
1985-1991
Uppsala University
Fil kand (Molecular Biology)
1983-1985
Umeå University
Biology
1982-1983
Anders Dahlstrand Skills
Alzheimer's disease
Antibody Drug Development
BioPharma Partnership
Biomarkers
Chronic Pain Disorders
Drug Discovery
Image Analysis
Immunohistochemistry
Molecular Pathology
Multiple Sclerosis
Neurodegenerative Disease
Neuroimmunology
Preclinical Development Strategy
Project Management
Tissue Based Assays
Translational Medicine
in Situ Hybridization
Neurobiology
Molecular Imaging
Histology
Histopathology
Chronic pain states
Neuroendocrinology
Stereology
Glia biology
Life Sciences
Drug Development
Pharmaceutical Industry
Neuroscience
Science
Marketing
Development
Molecular Biology
Business Development
Public Speaking
Biochemistry
Customer Service
Molecular
Anders Dahlstrand Summary
Anders Dahlstrand, based in Stockholm, SE, is currently a Chief Business Officer and Co-Founder at Offspring Biosciences AB at Offspring Biosciences AB. Anders Dahlstrand brings experience from previous roles at Karolinska Institutet, AstraZeneca R&D and Karolinska University Hospital. Anders Dahlstrand holds a 1985 - 1991 Dr. Med. Sci. in Molecular Neurobiology @ Karolinska Institutet. With a robust skill set that includes Alzheimer's disease, Antibody Drug Development, BioPharma Partnership, Biomarkers, Chronic Pain Disorders and more. Anders Dahlstrand has 4 emails on RocketReach.
Looking for a different Anders Dahlstrand?
Find contact details for 700 million professionals.